| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.540 | None | 1.000 | 5 | 1 | 1999 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 1.000 | 11 | 2 | 2004 | 2018 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.500 | None | 0.900 | 10 | 1 | 2009 | 2018 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 1.000 | 41 | 8 | 1999 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 1.000 | 40 | 4 | 2000 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 33 | 0 | 1997 | 2020 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.885 | 26 | 5 | 2000 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.880 | 25 | 1 | 2001 | 2019 | ||||||||
|
HOX transcript antisense RNA | 0.475 | 0.769 |
|
disease | 0.400 | None | 0.952 | 21 | 4 | 2014 | 2019 | |||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.950 | 20 | 0 | 2007 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 1.000 | 13 | 1 | 1998 | 2017 | ||||||||
|
major histocompatibility complex, class II, DP beta 2 (pseudogene) | 0.743 | 0.500 |
|
disease | 0.400 | None | 1.000 | 2 | 5 | 2013 | 2013 | |||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2007 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 1997 | 2018 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.350 | None | 0.667 | 6 | 0 | 2007 | 2018 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.340 | None | 1.000 | 5 | 1 | 2010 | 2017 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2008 | 2019 | ||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2002 | 2017 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.330 | None | 1.000 | 4 | 2 | 2014 | 2019 | ||||||||
|
ZNF667 antisense RNA 1 (head to head) | 0.691 | 0.308 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
POU class 4 homeobox 1 | 0.628 | 0.500 | 0.89 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 1998 | 2011 | ||||||||
|
YY1 transcription factor | 0.481 | 0.808 | 0.99 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2011 | 2018 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3B | 0.547 | 0.731 | 5.2E-16 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
microRNA 543 | 0.593 | 0.692 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2017 | 2019 |